Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07195071 · ClinicalTrials.gov registry record · NA
Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer Screening
A NA study of Hereditary Cancer Syndrome, sponsored by Columbia University.
- Recruiting
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 1
- Study location
NCT07195071 is a NA study of Hereditary Cancer Syndrome that is actively recruiting participants, run by Columbia University. The registered enrollment target is 1,000 participants, above the 508-participant average among 4 other Hereditary Cancer Syndrome trials with a reported enrollment target (97% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07195071, a NA study of Hereditary Cancer Syndrome, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators hypothesize that preconception and pregnancy may be a feasible and effective time to offer inherited cancer risk screening. This study will assess interest in cancer genetic testing among patients receiving routine prenatal care or preconception care. The goal is to evaluate the acceptability of hereditary cancer testing when offered alongside standard prenatal genetic screening. The study will also explore whether universal screening in this population could support early cancer prevention
Conditions Studied
Interventions
- DEVICE Natera empower comprehensive hereditary cancer panel
- DEVICE Obstetrical carrier screening
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2026-02-12 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07195071
The ClinicalTrials.gov registry entry for NCT07195071 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 508-participant average among 4 other Hereditary Cancer Syndrome trials with a reported enrollment target (97% higher). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hereditary Cancer Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Natera empower comprehensive hereditary cancer panel is the first listed.
NCT07195071 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07195071 about?
NCT07195071 is a clinical study titled "Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer Screening". The investigators hypothesize that preconception and pregnancy may be a feasible and effective time to offer inherited cancer risk screening. This study will assess interest in cancer genetic testing among patients receiving routine prenatal care or preconception care. The goal is to evaluate the ac...
What is the current status of trial NCT07195071?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2026-02-12. Estimated completion is 2028-12-31.
What conditions does trial NCT07195071 study?
This clinical trial studies the following conditions: Hereditary Cancer Syndrome.
What interventions are being tested in trial NCT07195071?
The interventions under investigation include: Natera empower comprehensive hereditary cancer panel (DEVICE), Obstetrical carrier screening (DEVICE).
Who is sponsoring clinical trial NCT07195071?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07195071 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hereditary Cancer Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment
RECRUITING · NA
-
Implementation of Population Cancer Genetic Services in Federally Qualified Health Centers (FQHC)
RECRUITING · NA
-
Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
RECRUITING
-
Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.